Article Text

PDF
THU0042 Longitudinal IP-10 serum levels associate with the course of disease activity and achieving dmard-free sustained remission in rheumatoid arthritis
  1. A van Hooij1,
  2. D Boeters2,
  3. E Tjon Kon Fat3,
  4. S van den Eeden1,
  5. P Corstjens3,
  6. A van der Helm-van Mil2,
  7. A Geluk1
  1. 1Department of Infectious diseases
  2. 2Department of Rheumatology
  3. 3Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, Netherlands

Abstract

Background Although rheumatoid arthritis (RA) is a chronic autoimmune disease that is persistent in the majority of patients, 10–15% of the RA patients achieve disease modifying anti-rheumatic drugs (DMARD)-free sustained remission over time. Biological mechanisms underlying the persistence of inflammation in RA are yet unidentified. It is well established that increased serum levels of IFN-γ-induced protein 10 (IP-10) are associated with (acute) increased inflammatory responses against mycobacterial pathogens causing leprosy and tuberculosis, thereby providing useful diagnostic tools in these infectious diseases. Based on previous genetic susceptibility studies, we hypothesize that there is an overlap between inflammatory responses observed in these mycobacterial diseases and those observed in RA. Therefore, we determined the association between serial IP-10 serum levels and achieving DMARD-free sustained remission as well as disease activity scores (DAS)-remission.

Objectives To 1) assess the association between IP-10 levels over time in patients that have persistent RA versus patients that achieve DMARD-free sustained remission, and 2) determine the association between IP-10 levels and DAS.

Methods 139 serum samples of 34 RA-patients (1987-criteria), obtained at the time of diagnoses and at yearly intervals thereafter, were studied. 15 patients had persistent RA and 19 patients achieved DMARD-free sustained remission after a median follow up of 2.7 years. IP-10 serum levels were measured using a previously developed, user-friendly lateral flow assay. Baseline and change in IP-10 levels over time were compared between patients with persistent RA and those achieving DMARD-free sustained remission. The association between the change in IP-10 level and the change in DAS was studied; in addition the course of the absolute IP-10 levels and the DAS over time was plotted for individual patients.

Results IP-10 serum levels varied from 316 – 53,685 pg/ml between RA-patients. Patients that had persistent arthritis or achieved DMARD-free sustained remission over time did not differ in baseline IP-10 levels (median persistent RA 1991 pg/ml and median DMARD-free sustained remission 3292 pg/ml, p=0.19). However, a significant decrease in IP-10 levels over time was observed in patients achieving DMARD-free sustained remission (p=0.003), whereas IP-10 levels remained stable in patients with persistent RA. Changes in IP-10 levels correlated well with changes in DAS scores (p=0.05). Also at the level of individual patients, a strong correlation between IP-10 levels and DAS over time was observed.

Conclusions These longitudinal data indicate that IP-10 levels are associated with perseverance of RA as well as with disease activity. Rapid diagnostic tests measuring IP-10 levels can therefore be helpful in monitoring of RA patients.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.